An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression

Y. R. Rubinstein, P. H. Driggers, V. V. Ogryzko, A. M. Thornton, K. Ozato, C. H. Pontzer

Research output: Contribution to journalArticle

Abstract

In order to study interferon regulatory factor (IRF) family mediation of cell growth regulation, we established U937 cell lines stably transfected with a truncated form of IRF-2 lacking the transcriptional repressor domain. The truncated IRF-2 contained the DNA binding domain (DBD) and bound the ISRE. Phenotypically, the IRF-2 DBD transfectants exhibited reduced cell growth, altered morphology and increased cell death. Consistent with alterations in growth characteristics, the IRF-2 DBD transfectants constitutively expressed higher levels of the cyclin dependent kinase inhibitor p21(WAF1/Cip1) than did control clones. The level of p21(WAF1/Cip1) expression was positively correlated with the level of DBD expressed, as well as with the level of growth inhibition in these clones. DBD expression also correlated with expression of other members of the growth regulatory complex, cyclin dependent kinase 2 and cyclin A, but not proliferating cell nuclear antigen. These results imply active repression by IRF-2 to keep p21(WAF1/Cip1) transcriptionally silent.

Original languageEnglish (US)
Pages (from-to)1411-1418
Number of pages8
JournalOncogene
Volume19
Issue number11
StatePublished - Mar 9 2000
Externally publishedYes

Fingerprint

Interferon Regulatory Factor-2
Gene Expression
DNA
Growth
Clone Cells
Interferon Regulatory Factors
Cyclin-Dependent Kinase 2
Cyclin-Dependent Kinase Inhibitor p21
Cyclin A
U937 Cells
Proliferating Cell Nuclear Antigen
Cell Death
Cell Line

Keywords

  • Cell growth
  • Interferon
  • Interferon regulatory factor

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Rubinstein, Y. R., Driggers, P. H., Ogryzko, V. V., Thornton, A. M., Ozato, K., & Pontzer, C. H. (2000). An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression. Oncogene, 19(11), 1411-1418.

An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression. / Rubinstein, Y. R.; Driggers, P. H.; Ogryzko, V. V.; Thornton, A. M.; Ozato, K.; Pontzer, C. H.

In: Oncogene, Vol. 19, No. 11, 09.03.2000, p. 1411-1418.

Research output: Contribution to journalArticle

Rubinstein, YR, Driggers, PH, Ogryzko, VV, Thornton, AM, Ozato, K & Pontzer, CH 2000, 'An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression', Oncogene, vol. 19, no. 11, pp. 1411-1418.
Rubinstein YR, Driggers PH, Ogryzko VV, Thornton AM, Ozato K, Pontzer CH. An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression. Oncogene. 2000 Mar 9;19(11):1411-1418.
Rubinstein, Y. R. ; Driggers, P. H. ; Ogryzko, V. V. ; Thornton, A. M. ; Ozato, K. ; Pontzer, C. H. / An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression. In: Oncogene. 2000 ; Vol. 19, No. 11. pp. 1411-1418.
@article{0a5c366ca41540fc86a327dd58fc4a08,
title = "An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression",
abstract = "In order to study interferon regulatory factor (IRF) family mediation of cell growth regulation, we established U937 cell lines stably transfected with a truncated form of IRF-2 lacking the transcriptional repressor domain. The truncated IRF-2 contained the DNA binding domain (DBD) and bound the ISRE. Phenotypically, the IRF-2 DBD transfectants exhibited reduced cell growth, altered morphology and increased cell death. Consistent with alterations in growth characteristics, the IRF-2 DBD transfectants constitutively expressed higher levels of the cyclin dependent kinase inhibitor p21(WAF1/Cip1) than did control clones. The level of p21(WAF1/Cip1) expression was positively correlated with the level of DBD expressed, as well as with the level of growth inhibition in these clones. DBD expression also correlated with expression of other members of the growth regulatory complex, cyclin dependent kinase 2 and cyclin A, but not proliferating cell nuclear antigen. These results imply active repression by IRF-2 to keep p21(WAF1/Cip1) transcriptionally silent.",
keywords = "Cell growth, Interferon, Interferon regulatory factor",
author = "Rubinstein, {Y. R.} and Driggers, {P. H.} and Ogryzko, {V. V.} and Thornton, {A. M.} and K. Ozato and Pontzer, {C. H.}",
year = "2000",
month = "3",
day = "9",
language = "English (US)",
volume = "19",
pages = "1411--1418",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression

AU - Rubinstein, Y. R.

AU - Driggers, P. H.

AU - Ogryzko, V. V.

AU - Thornton, A. M.

AU - Ozato, K.

AU - Pontzer, C. H.

PY - 2000/3/9

Y1 - 2000/3/9

N2 - In order to study interferon regulatory factor (IRF) family mediation of cell growth regulation, we established U937 cell lines stably transfected with a truncated form of IRF-2 lacking the transcriptional repressor domain. The truncated IRF-2 contained the DNA binding domain (DBD) and bound the ISRE. Phenotypically, the IRF-2 DBD transfectants exhibited reduced cell growth, altered morphology and increased cell death. Consistent with alterations in growth characteristics, the IRF-2 DBD transfectants constitutively expressed higher levels of the cyclin dependent kinase inhibitor p21(WAF1/Cip1) than did control clones. The level of p21(WAF1/Cip1) expression was positively correlated with the level of DBD expressed, as well as with the level of growth inhibition in these clones. DBD expression also correlated with expression of other members of the growth regulatory complex, cyclin dependent kinase 2 and cyclin A, but not proliferating cell nuclear antigen. These results imply active repression by IRF-2 to keep p21(WAF1/Cip1) transcriptionally silent.

AB - In order to study interferon regulatory factor (IRF) family mediation of cell growth regulation, we established U937 cell lines stably transfected with a truncated form of IRF-2 lacking the transcriptional repressor domain. The truncated IRF-2 contained the DNA binding domain (DBD) and bound the ISRE. Phenotypically, the IRF-2 DBD transfectants exhibited reduced cell growth, altered morphology and increased cell death. Consistent with alterations in growth characteristics, the IRF-2 DBD transfectants constitutively expressed higher levels of the cyclin dependent kinase inhibitor p21(WAF1/Cip1) than did control clones. The level of p21(WAF1/Cip1) expression was positively correlated with the level of DBD expressed, as well as with the level of growth inhibition in these clones. DBD expression also correlated with expression of other members of the growth regulatory complex, cyclin dependent kinase 2 and cyclin A, but not proliferating cell nuclear antigen. These results imply active repression by IRF-2 to keep p21(WAF1/Cip1) transcriptionally silent.

KW - Cell growth

KW - Interferon

KW - Interferon regulatory factor

UR - http://www.scopus.com/inward/record.url?scp=0034624711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034624711&partnerID=8YFLogxK

M3 - Article

C2 - 10723132

AN - SCOPUS:0034624711

VL - 19

SP - 1411

EP - 1418

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 11

ER -